QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
The paper “ Assessing cost-effectiveness of early intervention in Alzheimer’s disease: An open-source modeling framework”, co-authored by Quantify, has been published in Alzheimer’s & Dementia
The paper “ Assessing cost-effectiveness of early intervention in Alzheimer’s disease: An open-source modeling framework”, co-authored by Quantify’s Anders Gustavsson has been published in Alzheimer’s & Dementia.
This paper presents the development of an anticipated open-source model which can be used to evaluate disease modifying treatment in Alzheimer’s disease. The model was developed by researchers in a work group affiliated to the International Pharmaco-Economic Collaboration on Alzheimer’s Disease (IPECAD). A […]
Quantify shares market access expertise with LIF and industry colleagues
Yesterday we shared our expertise in health technology assessment in Sweden with LIF and industry colleagues. Interested in learning about market access, HTA, or health economics? Drop us a line at info@quantifyresearch.com or +46 707 36 55 69!
The paper ‘The association between patient reported outcomes of spinal surgery and societal costs – a register based study’, co-authored by Quantify, has been published in Spine.
The paper ‘The association between patient reported outcomes of spinal surgery and societal costs – a register based study’, co-authored by Quantify’s Amanda Hansson-Hedblom, Emma Söreskog and Fredrik Borgström has been published in Spine.
The paper is a register-based study combining Swedish register data including data from the quality register Swespine to analyse cost patterns over patient-reported outcomes of spine surgery. It was concluded that different self-reported […]
Interested in RWD, RWE, Nordic data, or longitudinal data analytics? Sign up for Quantify’s ISPOR courses!
Are you interested in RWD, RWE, Nordic data, or longitudinal data analytics? Then we warmly encourage you to sign up for Quantify’s ISPOR courses “Why All the Hype? Nordic Data Explained” and “Analysis of Longitudinal Data – Fixed and Random Effects Models”. The courses will be held on November 2nd at ISPOR Europe 2019 in Copenhagen and are led by Quantify’s Kirk Geale, Fredrik Borgström, Hanna Fues Wahl and Ingrid […]